MB
RLMD icon

MPM BioImpact’s Relmada Therapeutics RLMD Stock Holding History

MPM BioImpact’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-138,000
Closed -$3.73M – 40
2022
Q1 		$3.73M Buy
+138,000
New +$3.73M 1% 29